Baboon Marrow Transplant

I am compelled to respond to the recent commentary by Michal Jasienski entitled "Wishful Thinking And The Fallacy Of Single-Subject Experimentation" (The Scientist, March 4, 1996, page 10). The commentary presents a viewpoint regarding the appropriateness of the attempt to use baboon bone marrow for AIDS treatment involving a single patient (S. Benowitz, The Scientist, March 4, 1996, page 3). Contained in the commentary are misinformed statements regarding single-subject experimentation. The m

Written byJanine Janosky
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I am compelled to respond to the recent commentary by Michal Jasienski entitled "Wishful Thinking And The Fallacy Of Single-Subject Experimentation" (The Scientist, March 4, 1996, page 10).

The commentary presents a viewpoint regarding the appropriateness of the attempt to use baboon bone marrow for AIDS treatment involving a single patient (S. Benowitz, The Scientist, March 4, 1996, page 3). Contained in the commentary are misinformed statements regarding single-subject experimentation. The most erroneous statements are as follows: "Single-subject studies, such as a widely publicized attempt to use baboon bone marrow for AIDS treatment involving a single patient, named Jeff Getty, represent a seriously flawed scientific methodology. Consequently, the results of all single-subject studies are bound to be erroneous" and "Experimentation on single subjects (and self-experimentation in particular) violates basic assumptions of scientific inquiry and must be abandoned. It precludes statistical analysis and lets the dark forces of wishful thinking and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies